Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for Blood Cell Recovery After Transplant in Leukemia
IRCT20140818018842N51Phase 2Recruiting
- Sponsor
- Tehran University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of eltrombopag in acute lymphoblastic leukemia (ALL), sponsored by Tehran University of Medical Sciences. Started Oct 2025; status: recruiting.
02
Drugs
eltrombopag
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on IRCT20140818018842N51.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140818018842N51.